In summary, these results indicate that GRAMD1B itself may act as an oncogenic factor in TNBC and can thus partly explain the tumor-suppressive effects of miR-4646-5p, which we discovered to directly bind to and downregulate GRAMD1B mRNA. This evidence concerns the gene GRAMD1B and neoplasm.